March 7, 2013
Wipro Technologies, the Global Information Technology, Consulting and Outsourcing business of Wipro Limited (NYSE: WIT), today announced the launch of the Wipro AssureHealth platform in partnership with Microsoft. This is primarily targeted at
to deliver innovative solutions for Remote Fetal Monitoring and Cardiac Care that will ensure high quality treatment at reduced costs, especially for chronic diseases.
The Wipro AssureHealth platform leverages Microsoft's Cloud, Mobility and Analytics offerings to allow care providers to monitor patients regularly and precisely. This is done through hosted services and mobile apps that integrate medical devices,
and 24/7 customer support, to deliver highly scalable solutions. This is a value based service aimed at revolutionizing user experience like never before.
The fetal monitoring service delivers accurate recordings of maternal, fetal heart rate and uterine activity from the expectant mother to the physician over his/her Mobile device thereby enhancing the doctors ability to provide enhanced care to patients. The fetal monitor is a small wearable wireless device that provides beltless monitoring of the mother and the baby in the womb. It accurately records maternal and fetal heart rate, and uterine activity, thereby providing information on fetal and maternal well-being. The device is suited for both antenatal care, and during active labor and delivery.
The cardiac solution is based on our Assurehealth software platform and delivers continuous wearable, ambulatory, non-obtrusive ECG data. It is designed to assist cardiologists to monitor and manage patients with angina, myocardial infarction, post cardiac procedures like stent, pacemaker and bypass as well as cardiac failures, from anywhere, through their smart phone or tablets. This avoids frequent visits to the OPD for follow up, the needless waiting time and anxiety for patients. This system also aids proactive management of complications, identifying them with intelligent analysis as and when they occur and addressing it based on evidence.